Grail, Inc. (NASDAQ:GRAL - Get Free Report) shares fell 4.4% during mid-day trading on Thursday . The company traded as low as $16.78 and last traded at $16.80. 206,992 shares traded hands during mid-day trading, a decline of 68% from the average session volume of 640,543 shares. The stock had previously closed at $17.58.
Analysts Set New Price Targets
A number of research firms recently weighed in on GRAL. Wolfe Research began coverage on Grail in a report on Friday, November 15th. They set a "peer perform" rating on the stock. Guggenheim assumed coverage on shares of Grail in a report on Thursday, October 17th. They issued a "neutral" rating on the stock. Finally, Morgan Stanley began coverage on shares of Grail in a research note on Wednesday, November 27th. They set an "equal weight" rating and a $16.00 target price for the company.
View Our Latest Stock Report on GRAL
Grail Price Performance
The company has a fifty day moving average of $18.32.
Insider Activity at Grail
In other Grail news, CFO Aaron Freidin sold 30,452 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $14.02, for a total transaction of $426,937.04. Following the transaction, the chief financial officer now owns 268,277 shares in the company, valued at $3,761,243.54. This trade represents a 10.19 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Hedge Funds Weigh In On Grail
Several institutional investors and hedge funds have recently modified their holdings of GRAL. Douglas Lane & Associates LLC bought a new stake in Grail in the 4th quarter valued at about $3,034,000. A. D. Beadell Investment Counsel Inc. bought a new position in shares of Grail during the fourth quarter worth approximately $430,000. FNY Investment Advisers LLC acquired a new stake in shares of Grail in the fourth quarter valued at approximately $26,000. 180 Wealth Advisors LLC bought a new stake in shares of Grail in the fourth quarter valued at approximately $1,681,000. Finally, B & T Capital Management DBA Alpha Capital Management acquired a new stake in Grail during the fourth quarter worth approximately $387,000.
About Grail
(
Get Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Featured Stories
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
